Irosustat Terminated Phase 2 Trials for Endometrial Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01251354Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy